Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma Epidemiology of Outcomes (LEO) Cohort

被引：0
|
作者：
Bommier, Come [1 ,2 ]
Tsang, Mazie [3 ]
Noble, Brie N. [4 ]
Thompson, Carrie [5 ]
Casulo, Carla [6 ]
Hildebrandt, Michelle [7 ]
Rosenthal, Allison C. [8 ]
Mou, Eric [9 ]
Durani, Urshila [5 ]
Williams, Annalynn M. [10 ]
Yost, Kathleen [11 ]
Larson, Melissa C. [1 ]
Gysbers, Brianna [12 ]
Maurer, Matthew J. [13 ]
Feldman, Andrew L. [14 ]
Jaye, David L. [15 ]
Martin, Peter [16 ]
Cohen, Jonathon B. [17 ]
Chihara, Dai [18 ]
Lossos, Izidore S. [19 ]
Strouse, Christopher [20 ]
Kahl, Brad S. [21 ]
Habermann, Thomas M. [5 ]
Flowers, Christopher R.
Dueck, Amylou Constance [4 ]
Cerhan, James R. [13 ]
机构：
[1] Mayo Clin, Div Epidemiol, Rochester, MN USA
[2] Univ Paris Cite, Hematol Oncol, Hop St Louis, Inserm U1153, Paris, France
[3] Mayo Clin, Phoenix, AZ USA
[4] Mayo Clin, Scottsdale, AZ USA
[5] Mayo Clin, Div Hematol, Rochester, MN USA
[6] Univ Rochester, Wilmot Canc Ctr, Rochester, NY USA
[7] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[8] Mayo Clin, Div Hematol & Med Oncol, Phoenix, AZ USA
[9] Univ Iowa, Div Hematol Oncol & Blood Marrow Transplantat, Iowa City, IA USA
[10] Univ Rochester, Rochester, NY USA
[11] Mayo Clin, Div Epidemiol, Dept Quantitat Hlth Sci, Rochester, MN USA
[12] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[13] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN USA
[14] Mayo Clin, Div Hematopathol, Dept Lab Med & Pathol, Rochester, MN USA
[15] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA USA
[16] Weill Cornell Med, Div Hematol & Med Oncol, New York, NY USA
[17] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[18] Univ Texas MD Anderson Canc Ctr Houston, Dept Lymphoma & Myeloma, Houston, TX USA
[19] Univ Miami, Div Hematol, Sylvester Comprehens Canc Ctr, Sch Med, Miami, FL USA
[20] Univ Iowa Hosp & Clin, Div Hematol, Holden Comprehens Canc Ctr, Oncol & Blood Marrow Transplantat, Iowa City, IA USA
[21] Washington Univ St Louis, Sch Med, St Louis, MO USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187056
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 44 条
  • [1] Patterns of Care and Impact of Initial Treatment in Peripheral T-Cell Lymphoma: Outcome Analysis from the Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (MER) Prospective Cohort Study
    Ruan, Jia
    Chen, Zhengming
    Larson, Melissa C.
    Bennani, N. Nora
    Wallace, Danielle
    Allen, Pamela B.
    Jaye, David L.
    Cohen, Jonathon B.
    Castillo, Luis Enrique Malpica
    Vega, Francisco
    Inghirami, Giorgio
    Mou, Eric
    Casulo, Carla
    Mehta-Shah, Neha
    Martin, Peter
    Maurer, Matthew J.
    Kahl, Brad S.
    Lossos, Izidore S.
    Cerhan, James R.
    Flowers, Christopher R.
    Feldman, Andrew L.
    BLOOD, 2023, 142
  • [2] Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature
    Bommier, Come
    Link, Brian K.
    Gysbers, Brianna J.
    Maurer, Matthew J.
    Larson, Melissa C.
    Khurana, Arushi
    Wang, Yucai
    Thompson, Carrie A.
    Chihara, Dai
    Alderuccio, Juan P.
    Koff, Jean L.
    Epperla, Narendranath
    Conconi, Annarita
    Lossos, Izidore S.
    Nowakowski, Grzegorz S.
    Feldman, Andrew L.
    Habermann, Thomas M.
    King, Rebecca L.
    Cerhan, James R.
    BLOOD ADVANCES, 2024, 8 (23) : 5939 - 5948
  • [3] Cumulative Incidence, Predictors, and Outcomes of Transformation to Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Patients with Marginal Zone Lymphoma
    Bommier, Come
    Link, Brian K.
    Gysbers, Brianna
    Maurer, Matthew J.
    Larson, Melissa C.
    Khurana, Arushi
    Wang, Yucai
    Thompson, Carrie
    Chihara, Dai
    Alderuccio, Juan Pablo
    Koff, Jean L.
    Lossos, Izidore S.
    Nowakowski, Grzegorz S.
    Feldman, Andrew L.
    Habermann, Thomas M.
    King, Rebecca L.
    Cerhan, James R.
    BLOOD, 2023, 142
  • [4] Therapy for patients with POD24 follicular lymphoma: Treatment patterns and outcomes from the Lymphoma Epidemiology of Outcomes (LEO) Consortium.
    Casulo, Carla
    Larson, Melissa C.
    Day, Jonathan R.
    Habermann, Thomas Matthew
    Lossos, Izidore S.
    Wang, Yucai
    Nastoupil, Loretta J.
    Strouse, Christopher
    Chihara, Dai
    Martin, Peter
    Cohen, Jonathon Brett
    Kahl, Brad S.
    Ruan, Jia
    Burack, Walter Richard
    Koff, Jean Louise
    Friedberg, Jonathan W.
    Cerhan, James Robert
    Flowers, Christopher
    Link, Brian K.
    Maurer, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Patients with marginal zone lymphoma: characteristics, treatment reality and outcome data from the German prospective TLN Registry
    Knauf, W.
    Abenhardt, W.
    Koenigsmann, M.
    Maintz, C.
    Sandner, R.
    Zahn, M. -O.
    Schnell, R.
    Houet, L.
    Tech, S.
    Jaenicke, M.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 185 - 185
  • [6] Impact of Large Cells and Ki-67% on Outcomes in Patients with Newly Diagnosed Marginal Zone Lymphoma - Results from a Multicenter Cohort Study
    Epperla, Narendranath
    Grover, Natalie S.
    Annunzio, Kaitlin
    Watkins, Marcus P.
    Torka, Pallawi
    Karmali, Reem
    Anampa-Guzman, Andrea Carolina
    Oh, Timothy S.
    Reves, Heather
    Tavakkoli, Montreh
    Hansinger, Emily
    Christian, Beth
    Thomas, Colin
    Barta, Stefan K.
    Geethakumari, Praveen Ramakrishnan
    Bartlett, Nancy L.
    Shouse, Geoffrey P.
    Olszewski, Adam J.
    BLOOD, 2023, 142
  • [7] The Combination of Umbralisib Plus Ublituximab Is Active in Patients with Relapsed or Refractory Marginal Zone Lymphoma (MZL): Results from the Phase 2 Global Unity-NHL Trial
    Chavez, Julio C.
    Goldschmidt, Neta
    Samaniego, Felipe
    Wrobel, Tomasz
    Cavallo, Federica
    Fonseca, Gustavo
    Yoon, Sung-Soo
    Drgona, Lubos
    Hawkes, Eliza
    Levi, Itai
    Miskin, Hari P.
    Sportelli, Peter
    O'Connor, Owen A.
    Fowler, Nathan H.
    Zinzani, Pier Luigi
    BLOOD, 2021, 138
  • [8] Stage-adapted radiotherapy for treatment of localized gastric marginal zone lymphoma in 304 patients: results of three consecutive prospective multicenter studies
    Reinartz, G.
    Eich, H. -T
    Sheikh-Mounessi, F.
    Liersch, R.
    Berdel, W.
    Willich, N.
    Koch, P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 31 - 31
  • [9] Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study
    Muntanola, Ana
    Teresa Villalobos, Maria
    Gonzalez-Villambrosia, Sonia
    Rodriguez-Salazar, Maria Jose
    Jimenez-Ubieto, Ana
    Bastidas-Mora, Gabriela
    Cordoba, Raul
    Infante, Maria
    Jesus Vidal, Maria
    Javier Diaz, Francisco
    Baile, Monica
    Bastos-Oreiro, Mariana
    Panizo, Carlos
    Manuel Sancho, Juan
    Navarro, Belen
    Garcia, Tomas
    Escoda, Lourdes
    Abrisqueta, Pau
    Terol, Maria Jose
    de Campo, Raquel
    Mozas, Pablo
    Lopez-Guillermo, Armando
    Salar, Antonio
    Montalban, Carlos
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (04) : 776 - 784
  • [10] Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews
    Monga, Neerav
    Garside, Jamie
    Gurung, Binu
    Quigley, Joan
    O'Donovan, Peter
    Tapprich, Christoph
    Nastoupil, Loretta
    Thieblemont, Catherine
    Loefgren, Christina
    PHARMACOECONOMICS-OPEN, 2020, 4 (04) : 575 - 591
12345